You can buy or sell PCSA and other stocks, options, and ETFs commission-free!
Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its lead product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica.
52 Week High
52 Week Low
-$0.10 per share
Available May 13, After Hours